JP2025506707A5 - - Google Patents

Info

Publication number
JP2025506707A5
JP2025506707A5 JP2024548612A JP2024548612A JP2025506707A5 JP 2025506707 A5 JP2025506707 A5 JP 2025506707A5 JP 2024548612 A JP2024548612 A JP 2024548612A JP 2024548612 A JP2024548612 A JP 2024548612A JP 2025506707 A5 JP2025506707 A5 JP 2025506707A5
Authority
JP
Japan
Prior art keywords
product according
core
food product
layered
api
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024548612A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025506707A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/013334 external-priority patent/WO2023158816A1/en
Publication of JP2025506707A publication Critical patent/JP2025506707A/ja
Publication of JP2025506707A5 publication Critical patent/JP2025506707A5/ja
Pending legal-status Critical Current

Links

JP2024548612A 2022-02-18 2023-02-17 多機能活性医薬成分の多段階投与のための層状食用製品 Pending JP2025506707A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263311893P 2022-02-18 2022-02-18
US63/311,893 2022-02-18
PCT/US2023/013334 WO2023158816A1 (en) 2022-02-18 2023-02-17 Layered edible product for multi-stage dosing of multi-function active pharmaceutical ingredients

Publications (2)

Publication Number Publication Date
JP2025506707A JP2025506707A (ja) 2025-03-13
JP2025506707A5 true JP2025506707A5 (cg-RX-API-DMAC7.html) 2026-02-24

Family

ID=87573342

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024548612A Pending JP2025506707A (ja) 2022-02-18 2023-02-17 多機能活性医薬成分の多段階投与のための層状食用製品

Country Status (8)

Country Link
US (2) US20230263726A1 (cg-RX-API-DMAC7.html)
EP (1) EP4479039A4 (cg-RX-API-DMAC7.html)
JP (1) JP2025506707A (cg-RX-API-DMAC7.html)
KR (1) KR20250023333A (cg-RX-API-DMAC7.html)
AU (1) AU2023220095A1 (cg-RX-API-DMAC7.html)
CA (1) CA3252804A1 (cg-RX-API-DMAC7.html)
IL (1) IL315048A (cg-RX-API-DMAC7.html)
WO (1) WO2023158816A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2026076420A1 (en) * 2024-10-03 2026-04-09 Transport Authority, Inc. Method and apparatus for delivering an api-containing liquid to an edible substrate

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005010080B4 (de) * 2005-03-03 2008-04-03 Qimonda Ag Verfahren zum Herstellen einer Dünnschicht-Struktur
WO2016164464A1 (en) * 2015-04-07 2016-10-13 Church & Dwight Co., Inc. Multicomponent gummy compositions with hard core
US10772837B2 (en) * 2017-03-16 2020-09-15 CannTab Therapeutics, Ltd Modified release multi-layer tablet cannabinoid formulations
WO2018236729A1 (en) * 2017-06-18 2018-12-27 Cure Pharmaceutical Multi-layered high dosage dissolvable film for oral administration
US10925853B2 (en) * 2019-04-17 2021-02-23 Nordiccan A/S Oral cannabinoid tablet
KR102495558B1 (ko) * 2019-05-06 2023-02-06 아토믹 헬스 인코포레이티드 대마 식용품 제조 시스템 및 방법, 및 결과적인 식용 제품
AU2021307693A1 (en) * 2020-07-15 2023-02-23 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Oral cavity polymeric delivery systems

Similar Documents

Publication Publication Date Title
Irusa et al. Potential oral health effects of e‐cigarettes and vaping: A review and case reports
ES2986362T3 (es) Composiciones de goma de mascar que contienen nicotina
KR101819903B1 (ko) 구강 삽입용 투여 제형
JP4526384B2 (ja) カンナビス活性成分の投与のためのフィルム型粘着性投与形態
Vellappally et al. Smoking related systemic and oral diseases
JP5710121B2 (ja) トロメタモールを緩衝性作用物質として含有する、ニコチンの口腔内送り込み用薬用製品
US20200054551A1 (en) Sublingual Cannabis Dosage Form and Methods of Making and Using the Same
BRPI1001980A2 (pt) forma de dosagem intraoral de méltiplas partes com propriedades organolÉpticas
JP2017517490A (ja) 医療用チューインガム
BRPI0711168A2 (pt) composição transmucosal
US20240009171A1 (en) Compositions and methods for delivery of psilocin and prodrugs thereof
EP1885196A1 (en) Confectionery products for the treatment of dry mouth
US20060182786A1 (en) Transmucosal form of administration with reduced mucosal irritation
JP2024502598A5 (cg-RX-API-DMAC7.html)
US10695292B2 (en) Chewing gum composition for use in alleviation of xerostomia induced by radiotherapy treatment
JP2023145488A (ja) ドライアイの処置のための組成物およびその使用の方法
JP2006511543A (ja) 安定なトピラメート製剤
IL315048A (en) Layered edible product for multi-stage dosing of multi-function active pharmaceutical ingredients
Shah et al. Comparison of systemic and topical forms of curcumin in oral submucous fibrosis: A clinical and histopathological evaluation in 120 patients
Vikneshan et al. Smokeless tobacco and its adverse effects on oral cavity-an overview
J Tangso et al. Confectionery-based dose forms
WO2018009500A1 (en) Oral dosage form containing a fast release exterior coating
US20100256215A1 (en) Menthol-Melatonin Dissolving Film
JPS6168415A (ja) 口腔粘膜適用口臭除去剤
EP4591876A1 (en) Diamine oxidase (dao) for use in the treatment and/or prevention of sleep and circadian rhythm disorders, and cognitive impairment associated thereto